hemodialysis -patient.
Conditions
Interventions
This study doesn’t have a control group. It will be conducted with one group of hemodialysis patients. Group hope therapy will be conducted with five hemodialysis patients in each group. The contents
Sponsors
Khoram-Abad University of Medical Sciences
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: The patients are within the age limit of 18-65 The patient should be interested in the research and in participating in the training sessions. The patients have undergone hemodialysis for one month. The patients should undergo hemodialysis 3 times a week. A doctor should introduce the patient to participate in the study The patient should not suffer from mental disorders The patient?s have not taken Psychiatric medicines The patients should promise not to use other methods for decreasing anxiety during the hope therapy. The patients should be able to participate in all of the group hope therapy sessions Patients’ anxiety score that is higher than the anxiety level should be trivial
Exclusion criteria
Exclusion criteria: Lack of patients’ interest in continuing the research The use of anxiety-reducing medicines or other therapies for anxiety Having chronic and debilitating diseases based on doctor’s diagnosis Having severe anxiety disorders such as phobia and panic attack during dialysis Patient death Patient emigration Having visual, hearing, and speech impairment Patients not being in good physical condition Being absent for sessions Not being able to participate in hope therapy sessions during the research Changing the treatment approach(kidney transplant, peritoneal dialysis) Severe family and social crises ( the death of a member of the immediate family, job, divorce, dropout) Participating and following other training programs which affects anxiety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score anxiety the hidden and on the basis of a questionnaire, anxiety eshpilberger. Timepoint: Before the start of the intervention, immediately after the intervention and one months after the interventiond and three months after the intervention. Method of measurement: Scale obtained from Spielberger's revealing and hidden anxiety questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| The score of medication adherance in the hemodialysis patients to the questioneria ESRD-AQ. Timepoint: Before the start of the intervention, immediately after the intervention and one month after the intervention and three months after the intervention. Method of measurement: the result of the questionnaire was to follow the treatment of hemodialysis patients according to the questionnaire - ESRD-AQ. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Ahmadi Fajr
Khoram-Abad University of Medical Sciences
Outcome results
None listed